TY - JOUR
T1 - Glucagon and the a Cell
T2 - Physiology and Pathophysiology
AU - Unger, Roger H
AU - Orci, L.
PY - 1981/6/18
Y1 - 1981/6/18
N2 - IN this review we examine the role of glucagon, a polypeptide produced by the islets of Langerhans and a biologic antagonist of insulin. The effects of glucagon balance those of insulin so that fluctuations in blood sugar levels in response to sudden changes in fluxes of fuels are prevented. By definition, relative hyperglucagonemia is present in all forms of diabetes in which glucose production exceeds glucose disposal and thus causes “endogenous hyperglycemia”; in the absence of glucagon-like biologic activity the massive hepatic overproduction of glucose and ketones observed in uncontrolled diabetes does not occur, even in the total absence of. . .
AB - IN this review we examine the role of glucagon, a polypeptide produced by the islets of Langerhans and a biologic antagonist of insulin. The effects of glucagon balance those of insulin so that fluctuations in blood sugar levels in response to sudden changes in fluxes of fuels are prevented. By definition, relative hyperglucagonemia is present in all forms of diabetes in which glucose production exceeds glucose disposal and thus causes “endogenous hyperglycemia”; in the absence of glucagon-like biologic activity the massive hepatic overproduction of glucose and ketones observed in uncontrolled diabetes does not occur, even in the total absence of. . .
UR - http://www.scopus.com/inward/record.url?scp=0019861204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019861204&partnerID=8YFLogxK
U2 - 10.1056/NEJM198106183042504
DO - 10.1056/NEJM198106183042504
M3 - Review article
C2 - 7015132
AN - SCOPUS:0019861204
SN - 0028-4793
VL - 304
SP - 1518
EP - 1524
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 25
ER -